Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT251 Injection in Overweight/Obese Patients
NCT07648225Phase 3Not yet recruiting
- Start
- Jul 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 3 trial of UBT251 in obesity. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
UBT251
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07648225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648225.